Use of prasugrel in the setting of clopidogrel hypersensitivity: Case report and systematic review of the literature

References

• Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, O’Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007;49:734–739.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494–502.
   Google Scholar
• Campbell KL, Cohn JR, Savage MP. Clopidogrel hypersensitivity: Clinical challenges and options for management. Expert Rev Clin Pharmacol 2010;3:553–561.
   PubMedGoogle Scholar
• CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–1339.
   PubMed Web of Science ®Google Scholar
• Siu H, Kaliyadan A, Campbell KL, Fischman DL, Ruggiero N, Walinsky P, Savage MP. Management of clopidogrel hypersensitivity. In: Alesci JP, Victorino A, Editors. Clopidogrel: Pharmacology, Clinical Uses and Adverse Effects. New York: Nova Science Publishers, Inc; 2014. pp. 149–173.
   Google Scholar
• Cheema AN, Mohammad A, Hong T, Jakubovic HR, Parmar GS, Sharieff W, Garvey MB, Kutryk MJB, Fam NP, Graham JJ, Chisholm RJ. Characterization of clopidogrel hypersensitivity reactions and management with oral steroids without clopidogrel discontinuation. J Am Coll Cardiol 2011;58:1445–1454.
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Braber TL, Verheggen PW, Van Der Have-Roeffel SM. Prasugrel as alternative treatment strategy in a case with a hypersensitivity reaction to clopidogrel. Platelets 2011;22:77–78.
   PubMed Web of Science ®Google Scholar
• Chopra P, Verma P, Klaustermeyer WB. Successful use of prasugrel, an alternative antiplatelet agent, in a patient with clopidogrel allergy. Ann Allergy Asthma Immunol 2011;107:541–542.
   PubMed Web of Science ®Google Scholar
• Peppard SR, Held-Godgluck BM, Beddingfield R. Use of prasugrel in a patient with clopidogrel hypersensitivity. Ann Pharmacother 2011;45:e54.
   PubMedGoogle Scholar
• Raccah BH, Shalit M, Danenberg D. Allergic reaction to prasugrel and cross-reactivity with clopidogrel. Int J Cardiol 2011; 157:e48–e49.
   PubMed Web of Science ®Google Scholar
• Kanadiya MK, Singhai S, Koshal VB. Prasugrel as a safe alternative for clopidogrel-associated arthritis. J Invasive Cardiol 2011;23:E137–E138.
   PubMedGoogle Scholar
• Coulter CJ, Montandon SV. Prasugrel as a safe alternative for clopidogrel-induced polyarthralgias. Pharmacotherapy 2012; 32: e24–e26.
   PubMed Web of Science ®Google Scholar
• Felix-Getzik E, Sylvia LM. Prasugrel use in a patient allergic to clopidogrel: Effect of a drug shortage on selection of dual antiplatelet therapy. Am J Health-Syst Pharm 2013;70:511–513.
   PubMed Web of Science ®Google Scholar
• Agrawal S, HarburgerJ, Stallings G, Agrawal N, Garg J. Clopidogrel-induced recurrent polyarthritis. J Investig Med High Impact Case Rep 2013; 1: 1–4.
   Google Scholar
• Williams MF, Maloof JA. Resolution of clopidogrel-associated polyarthritis after conversion to prasugrel. Am J Health-Syst Pharm 2014; 71:1097–1100.
   PubMed Web of Science ®Google Scholar
• Chin N, Rangamuwak K, Mariasoosai R, Cranes J, Thien F. Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitization. Asia Pac Allergy 2015;5:51–54.
   PubMedGoogle Scholar
• von Tiehl KF, Price MJ, Valencia R, Ludington KJ, Teirstein PS, Simon RA. Clopidogrel desensitization after drug-eluting stent placement. J Am Coll Cardiol 2007;50:2039–2043.
   PubMed Web of Science ®Google Scholar
• Camara MG, Almeda FQ. Clopidogrel (Plavix) desensitization: A case series. Catheter Cardiovasc Interv 2005;65:525–527.
   PubMed Web of Science ®Google Scholar
• Campbell KL, Cohn JR, Fischman DL, Walinsky P, Mallya R, Jaffrani W, Savage MP. Management of clopidogrel hypersensitivity without drug interruption. Am J Cardiol 2011;107:812–816.
   PubMed Web of Science ®Google Scholar
• Li YG, Brandt JT, Small DS, Payne CD, Ernest CS, Rohatagi S,Farid NA, Jakubowski JA, Winters KJ. Inhibition of platelet aggregation with prasugrel and clopidogrel: An integrated analysis in 846 subjects. Platelets 2009; 20: 316–327.
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001–2015.
   PubMed Web of Science ®Google Scholar
• Lokhandwala JO, Best PJ, Butterfield JH, Skelding KA, Scott T, Blankenship JC, Buckley JW, Berger PB. Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel. Circ Cardiovasc Interv 2009;2:348–351.
   PubMed Web of Science ®Google Scholar
• Harris JR, Coons JC. Ticagrelor use in a patient with a documented clopidogrel hypersensitivity. Ann Pharmacother 2014;48:1230–1233.
   PubMed Web of Science ®Google Scholar
• Manchette AM, Drucker AG, Januzzi JL. Acute coronary syndrome antiplatelet alternatives in clopidogrel allergy. Pharmacotherapy 2014;34:e152–e156.
   PubMed Web of Science ®Google Scholar